Related Experiment Video
Updated: May 23, 2026

Studying the Stoichiometry of Epidermal Growth Factor Receptor in Intact Cells using Correlative Microscopy
Published on: September 11, 2015
NOK/STYK1 has a strong tendency towards forming aggregates and colocalises with epidermal growth factor receptor in
Xue Ding1, Qing-Bo Jiang, Rui Li
1State Key Laboratory of Biomembrane and Membrane Biotechnology, School of Life Sciences, Tsinghua University, Beijing 100084, China.
Abstract:
Our previous studies showed that the overexpression of Novel Oncogene with Kinase-domain (NOK)/STYK1 led to cellular transformation, tumorigenesis and metastasis. This report characterises the subcellular distribution of NOK in HeLa cells and its localisation in early endosomes. Confocal immunolocalisation studies indicated that NOK had structural subtypes and was distributed into two distinct expression patterns: a dot pattern (DP) and an aggregation pattern (AP). The results of an immunohistochemistry (IHC) analysis of pathological tissues also showed that high expression level of endogenous NOK was expressed in an aggregate-like structure in vivo. Importantly, we found that NOK was localised in endosomes and colocalised with epidermal growth factor receptor (EGFR) in activated endosomal vesicles. However, as the stimulation time increased, NOK and EGFR began to progress through different pathways. EGFR was gradually degraded after treatment with EGF for approximately 20 min, whereas NOK levels were not reduced. This result suggests that NOK mainly plays a role in facilitating the trafficking of EGFR from early endosomes to later endosomes/lysosomes. Taken together, NOK has a strong tendency towards forming aggregates, which may have physiological implications and provide the first evidence that this novel receptor kinase is colocalised with EGFR in endosomes to participate in a post-internalisation step of EGFR.
Insights
Novel Oncogene with Kinase-domain (NOK) aggregates in early endosomes and colocalizes with the epidermal growth factor receptor (EGFR). NOK facilitates EGFR trafficking, suggesting a role in post-internalization signaling.
Area of Science:
- Cell Biology
- Molecular Oncology
- Signal Transduction
Background:
- The Novel Oncogene with Kinase-domain (NOK)/STYK1 is implicated in cellular transformation, tumorigenesis, and metastasis.
- Understanding the subcellular localization and function of NOK is crucial for cancer research.
Purpose of the Study:
- To characterize the subcellular distribution of NOK in HeLa cells.
- To investigate the interaction of NOK with the epidermal growth factor receptor (EGFR).
- To elucidate the role of NOK in EGFR trafficking and signaling.
Main Methods:
- Confocal immunolocalization studies in HeLa cells.
- Immunohistochemistry (IHC) analysis of pathological tissues.
- Co-localization studies with EGFR and EGF stimulation.
Main Results:
- NOK exhibits distinct structural subtypes and expression patterns (dot and aggregation patterns).
- Endogenous NOK forms aggregate-like structures in vivo.
- NOK localizes to early endosomes and co-localizes with EGFR in activated endosomal vesicles.
- NOK facilitates EGFR trafficking from early endosomes to later endosomes/lysosomes, while NOK levels remain stable.
- NOK demonstrates a propensity for aggregate formation.
Conclusions:
- NOK's subcellular localization and aggregation tendency have significant physiological implications.
- This study provides the first evidence of NOK co-localization with EGFR in endosomes.
- NOK participates in the post-internalization steps of EGFR signaling, potentially influencing cancer progression.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Anchoring Junctions
Mitogens and the Cell Cycle
Intracellular Signaling Affects Focal Adhesions
Some...
Vesicular Tubular Clusters
With the help of motor proteins such...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
